Detalles de la búsqueda
1.
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors.
N Engl J Med
; 382(6): 545-553, 2020 02 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32023374
2.
The Clinicopathologic Features and Molecular Signatures of Blastoid High-Grade B Cell Lymphoma, Not Otherwise Specified.
Mod Pathol
; 36(12): 100349, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37820764
3.
Prostate cancer cells survive anti-androgen and mitochondrial metabolic inhibitors by modulating glycolysis and mitochondrial metabolic activities.
Prostate
; 81(12): 799-811, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34170017
4.
Nonphosphorylatable PEA15 mutant inhibits epithelial-mesenchymal transition in triple-negative breast cancer partly through the regulation of IL-8 expression.
Breast Cancer Res Treat
; 189(2): 333-345, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34241740
5.
Elevated serum levels of sialyl Lewis X (sLeX) and inflammatory mediators in patients with breast cancer.
Breast Cancer Res Treat
; 176(3): 545-556, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31054033
6.
Unique pathologic features and gene expression signatures distinguish blastoid high-grade B-cell lymphoma from B-acute lymphoblastic leukemia/lymphoma.
Haematologica
; 108(3): 895-899, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36325892
7.
Thrombocytosis as a prognostic factor in inflammatory breast cancer.
Breast Cancer Res Treat
; 166(3): 819-832, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28831670
8.
Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination.
Breast Cancer Res
; 16(5): 440, 2014 Sep 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-25223629
9.
Maintenance Pembrolizumab Therapy in Patients with Metastatic HER2-negative Breast Cancer with Prior Response to Chemotherapy.
Clin Cancer Res
; 30(11): 2424-2432, 2024 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38629963
10.
Gene expression profiling of circulating tumor cells captured by MicroCavity Array is superior to enumeration in demonstrating therapy response in patients with newly diagnosed advanced and locally advanced non-small cell lung cancer.
Transl Lung Cancer Res
; 12(1): 109-126, 2023 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-36762061
11.
Phenotypic Plasticity in Circulating Tumor Cells Is Associated with Poor Response to Therapy in Metastatic Breast Cancer Patients.
Cancers (Basel)
; 15(5)2023 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36900406
12.
Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy.
Int J Cancer
; 130(4): 808-16, 2012 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21387303
13.
Associations of cytokines, sleep patterns, and neurocognitive function in youth with HIV infection.
Clin Immunol
; 144(1): 13-23, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22659030
14.
Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells.
Breast Cancer Res Treat
; 134(2): 495-510, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22547109
15.
Identification of the JNK-Active Triple-Negative Breast Cancer Cluster Associated With an Immunosuppressive Tumor Microenvironment.
J Natl Cancer Inst
; 114(1): 97-108, 2022 01 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34250544
16.
Ensemble of nucleic acid absolute quantitation modules for copy number variation detection and RNA profiling.
Nat Commun
; 13(1): 1791, 2022 04 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35379811
17.
A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix® PC1 System.
Cancers (Basel)
; 14(21)2022 Oct 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36358657
18.
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer.
Sci Adv
; 8(50): eabn7983, 2022 12 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36525493
19.
Treatment with lenalidomide modulates T-cell immunophenotype and cytokine production in patients with chronic lymphocytic leukemia.
Cancer
; 117(17): 3999-4008, 2011 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21858802
20.
Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia.
Blood
; 111(11): 5291-7, 2008 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18334676